Climate Change Data

Tanvex BioPharma, Inc.

Climate Impact & Sustainability Data (2022)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:3,479.21 tCO2e/year
Scope 1 Emissions:1,057.24 tCO2e/year
Scope 2 Emissions:2,421.97 tCO2e/year
Renewable Energy Share:0%
Total Energy Consumption:40,551.06 GJ/year
Water Consumption:2,400 metric tons/year
Waste Generated:98.66 metric tons/year
Carbon Intensity:0.16 tCO2e/Thousand NTD Revenue

ESG Focus Areas

  • Governance
  • Product Quality
  • Social Care
  • Environmental Sustainability

Environmental Achievements

  • Total waste generated in 2022 was 98.66 metric tons, a decrease of 4.1% compared to 2021.
  • Water consumption in 2022 was 2,400 metric tons, a decrease of 7.1% compared to 2021.

Social Achievements

  • Tanvex BioPharma USA employed nearly 70% of its workforce from ethnic minorities.
  • 100% retention rate for employees on maternity leave.
  • Female employees accounted for 48% of the total workforce, with female employees making up 46% of managerial positions.
  • Provided training to 206 employees, accumulating 5,413 training hours.

Governance Achievements

  • Established a Sustainable Development Committee.
  • Implemented the first material topic sustainability impact assessment and identified 10 sustainability material topics.
  • Self-assessment results of the Board of Directors and individual directors’ performance evaluations all higher than 90.
  • Average attendance rate of the Audit Committee and Remuneration Committee was 100%.
  • No corruption or unethical behavior found in 2022.
  • No cybersecurity incidents occurred in 2022.

Climate Goals & Targets

Short-term Goals:
  • Reduce employee turnover to 20%

Environmental Challenges

  • Patent lawsuits with original manufacturers are inevitable.
  • Potential negative stakeholder feedback.
  • Extreme weather events causing damage to assets and supply chain disruptions.
  • Changes in precipitation patterns affecting water supply.
  • Rising mean temperatures increasing energy demands and costs.
Mitigation Strategies
  • Comprehensive legal consulting resources to resolve patent litigation.
  • Establish Sales and Marketing policies to maintain brand value.
  • Develop a Lifecycle Product Sustainability program.
  • Establish strategies to prevent extreme weather events from impairing supply chain.
  • Develop a two-supplier policy.
  • Establish a business continuity plan (BCP).
  • Evaluate water consumption and implement reduction measures.
  • Launch energy-saving measures.
  • All operational sites have emergency generators.
  • Procurement Department regularly tracks raw material futures prices.

Supply Chain Management

Supplier Audits: Mail-in audits and site audits depending on supplier criticality

Responsible Procurement
  • Purchasing Policy based on FDASIA Title VII, FDA ICH GMP guidance, and IPEC-PQG GMP Guide for Excipients
  • Vendor Management Program
  • New Supplier Set Up program
  • Supplier Qualification Program
  • BSE/TSE program
  • Inventory Control

Climate-Related Risks & Opportunities

Physical Risks
  • Increased severity and frequency of extreme weather events
  • Changes in precipitation patterns
  • Rising mean temperatures
Transition Risks
  • Increased stakeholder concern or negative stakeholder feedback
  • Enhanced emissions-reporting obligations
  • Carbon pricing mechanisms
Opportunities
  • Use of lower-emission sources of energy
  • Expanding demand for climate adaptation solutions

Reporting Standards

Frameworks Used: GRI Universal Standards 2021, SASB guidelines for the biopharmaceutical industry, TCFD